Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 162

1.

Streptococcus pneumoniae serotype 3 is masking PCV13-mediated herd immunity in Canadian adults hospitalized with community acquired pneumonia: A study from the Serious Outcomes Surveillance (SOS) Network of the Canadian immunization research Network (CIRN).

LeBlanc JJ, ElSherif M, Ye L, MacKinnon-Cameron D, Ambrose A, Hatchette TF, Lang ALS, Gillis HD, Martin I, Demczuk W, Andrew MK, Boivin G, Bowie W, Green K, Johnstone J, Loeb M, McCarthy AE, McGeer A, Semret M, Trottier S, Valiquette L, Webster D, McNeil SA.

Vaccine. 2019 Aug 23;37(36):5466-5473. doi: 10.1016/j.vaccine.2019.05.003. Epub 2019 Jul 23.

2.

Validation of the Seegene RV15 multiplex PCR for the detection of influenza A subtypes and influenza B lineages during national influenza surveillance in hospitalized adults.

LeBlanc JJ, ElSherif M, Mulpuru S, Warhuus M, Ambrose A, Andrew M, Boivin G, Bowie W, Chit A, Dos Santos G, Green K, Halperin SA, Hatchette TF, Ibarguchi B, Johnstone J, Katz K, Langley JM, Lagacé-Wiens P, Loeb M, Lund A, MacKinnon-Cameron D, McCarthy A, McElhaney JE, McGeer A, Poirier A, Powis J, Richardson D, Semret M, Shinde V, Smyth D, Trottier S, Valiquette L, Webster D, Ye L, McNeil SA.

J Med Microbiol. 2019 Jul 2. doi: 10.1099/jmm.0.001032. [Epub ahead of print]

PMID:
31264957
3.

Effectiveness of Influenza Vaccination on Hospitalizations and Risk Factors for Severe Outcomes in Hospitalized Patients With COPD.

Mulpuru S, Li L, Ye L, Hatchette T, Andrew MK, Ambrose A, Boivin G, Bowie W, Chit A, Dos Santos G, ElSherif M, Green K, Haguinet F, Halperin SA, Ibarguchi B, Johnstone J, Katz K, Langley JM, LeBlanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney JE, McGeer A, Powis J, Richardson D, Semret M, Shinde V, Smyth D, Trottier S, Valiquette L, Webster D, McNeil SA; Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN).

Chest. 2019 Jan;155(1):69-78. doi: 10.1016/j.chest.2018.10.044.

PMID:
30616737
4.

The Impact of Prior Season Vaccination on Subsequent Influenza Vaccine Effectiveness to Prevent Influenza-related Hospitalizations Over 4 Influenza Seasons in Canada.

Nichols MK, Andrew MK, Ye L, Hatchette TF, Ambrose A, Boivin G, Bowie W, Dos Santos G, Elsherif M, Green K, Haguinet F, Katz K, Leblanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney JE, McGeer A, Powis J, Richardson D, Semret M, Sharma R, Shinde V, Smyth D, Trottier S, Valiquette L, Webster D, McNeil SA; Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN).

Clin Infect Dis. 2019 Aug 30;69(6):970-979. doi: 10.1093/cid/ciy1009.

PMID:
30508064
5.

Influenza vaccine effectiveness to prevent influenza-related hospitalizations and serious outcomes in Canadian adults over the 2011/12 through 2013/14 influenza seasons: A pooled analysis from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS Network).

Nichols MK, Andrew MK, Hatchette TF, Ambrose A, Boivin G, Bowie W, Chit A, Dos Santos G, ElSherif M, Green K, Haguinet F, Halperin SA, Ibarguchi B, Johnstone J, Katz K, Lagacé-Wiens P, Langley JM, LeBlanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney JE, McGeer A, Poirier A, Powis J, Richardson D, Schuind A, Semret M, Shinde V, Smith S, Smyth D, Stiver G, Taylor G, Trottier S, Valiquette L, Webster D, Ye L, McNeil SA; Serious Outcomes Surveillance Network of the Canadian Immunization Research Network (CIRN), the Toronto Invasive Bacterial Diseases Network (TIBDN).

Vaccine. 2018 Apr 12;36(16):2166-2175. doi: 10.1016/j.vaccine.2018.02.093. Epub 2018 Mar 13.

PMID:
29548608
6.

Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in Canada.

Andrew MK, Shinde V, Hatchette T, Ambrose A, Boivin G, Bowie W, Chit A, Dos Santos G, ElSherif M, Green K, Haguinet F, Halperin SA, Ibarguchi B, Johnstone J, Katz K, Langley JM, LeBlanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney J, McGeer A, Nichols MK, Powis J, Richardson D, Semret M, Stiver G, Trottier S, Valiquette L, Webster D, Ye L, McNeil SA; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Serious Outcomes Surveillance Network and the Toronto Invasive Bacterial Diseases Network (TIBDN).

BMC Infect Dis. 2017 Dec 29;17(1):805. doi: 10.1186/s12879-017-2905-8.

7.

Resource utilization and cost of influenza requiring hospitalization in Canadian adults: A study from the serious outcomes surveillance network of the Canadian Immunization Research Network.

Ng C, Ye L, Noorduyn SG, Hux M, Thommes E, Goeree R, Ambrose A, Andrew MK, Hatchette T, Boivin G, Bowie W, ElSherif M, Green K, Johnstone J, Katz K, Leblanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney J, McGeer A, Poirier A, Powis J, Richardson D, Sharma R, Semret M, Smith S, Smyth D, Stiver G, Trottier S, Valiquette L, Webster D, McNeil SA; Serious Outcomes Surveillance Network of the Canadian Immunization Research Network (CIRN) Investigators; Toronto Invasive Bacterial Diseases Network (TIBDN) Investigators.

Influenza Other Respir Viruses. 2018 Mar;12(2):232-240. doi: 10.1111/irv.12521. Epub 2018 Jan 24.

8.

The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly People.

Andrew MK, Shinde V, Ye L, Hatchette T, Haguinet F, Dos Santos G, McElhaney JE, Ambrose A, Boivin G, Bowie W, Chit A, ElSherif M, Green K, Halperin S, Ibarguchi B, Johnstone J, Katz K, Langley J, Leblanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McGeer A, Powis J, Richardson D, Semret M, Stiver G, Trottier S, Valiquette L, Webster D, McNeil SA; Serious Outcomes Surveillance Network of the Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) and the Toronto Invasive Bacterial Diseases Network (TIBDN).

J Infect Dis. 2017 Aug 15;216(4):405-414. doi: 10.1093/infdis/jix282.

9.

Burden of vaccine-preventable pneumococcal disease in hospitalized adults: A Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) network study.

LeBlanc JJ, ElSherif M, Ye L, MacKinnon-Cameron D, Li L, Ambrose A, Hatchette TF, Lang AL, Gillis H, Martin I, Andrew MK, Boivin G, Bowie W, Green K, Johnstone J, Loeb M, McCarthy A, McGeer A, Moraca S, Semret M, Stiver G, Trottier S, Valiquette L, Webster D, McNeil SA; Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN).

Vaccine. 2017 Jun 22;35(29):3647-3654. doi: 10.1016/j.vaccine.2017.05.049. Epub 2017 May 26.

10.

Evaluation of a Clostridium difficile infection management policy with clinical pharmacy and medical microbiology involvement at a major Canadian teaching hospital.

Yeung SS, Yeung JK, Lau TT, Forrester LA, Steiner TS, Bowie WR, Bryce EA.

J Clin Pharm Ther. 2015 Dec;40(6):655-60. doi: 10.1111/jcpt.12329. Epub 2015 Nov 7.

PMID:
26547905
11.

Lyme disease: How reliable are serologic results?

Gregson D, Evans G, Patrick D, Bowie W.

CMAJ. 2015 Nov 3;187(16):1193-1194. doi: 10.1503/cmaj.150874. Epub 2015 Aug 31. No abstract available.

12.

Acute Kidney Injury With Tobramycin-Impregnated Bone Cement Spacers in Prosthetic Joint Infections.

Aeng ES, Shalansky KF, Lau TT, Zalunardo N, Li G, Bowie WR, Duncan CP.

Ann Pharmacother. 2015 Nov;49(11):1207-13. doi: 10.1177/1060028015600176. Epub 2015 Aug 12.

PMID:
26269097
13.

Successful methodology for large-scale surveillance of severe events following influenza vaccination in Canada, 2011 and 2012.

Bettinger JA, Rouleau I, Gariepy MC, Bowie WR, Valiquette L, Vanderkooi OG, Kellner JD, Coleman BL, McNeil SA, McCarthy A, De Serres G; Public Health Agency of Canada/Canadian Institutes for Health Research Influenza Research Network.

Euro Surveill. 2015 Jul 23;20(29):21189.

14.

Longitudinal clinical findings and outcome among patients with Cryptococcus gattii infection in British Columbia.

Phillips P, Galanis E, MacDougall L, Chong MY, Balshaw R, Cook VJ, Bowie W, Steiner T, Hoang L, Morshed M, Ghesquiere W, Forrest DM, Roscoe D, Doyle P, Kibsey PC, Connolly T, Mirzanejad Y, Thompson D; British Columbia Cryptococcus gattii Study Group.

Clin Infect Dis. 2015 May 1;60(9):1368-76. doi: 10.1093/cid/civ041. Epub 2015 Jan 28.

PMID:
25632012
15.

Antimicrobial co-resistance patterns of gram-negative bacilli isolated from bloodstream infections: a longitudinal epidemiological study from 2002-2011.

Wong PH, von Krosigk M, Roscoe DL, Lau TT, Yousefi M, Bowie WR.

BMC Infect Dis. 2014 Oct 12;14:393. doi: 10.1186/1471-2334-14-393.

16.

Increased moxifloxacin utilization associated with an unrestricted addition to a drug reimbursement formulary: A population-based analysis.

Wright AJ, Marra F, Chong M, Chambers C, Bowie WR, Patrick DM.

Can J Infect Dis Med Microbiol. 2014 Spring;25(1):27-31.

17.

Interim estimates of 2013/14 influenza clinical severity and vaccine effectiveness in the prevention of laboratory-confirmed influenza-related hospitalisation, Canada, February 2014.

McNeil S, Shinde V, Andrew M, Hatchette T, Leblanc J, Ambrose A, Boivin G, Bowie W, Diaz-Mitoma F, Elsherif M, Green K, Haguinet F, Halperin S, Ibarguchi B, Katz K, Langley J, Lagace-Wiens P, Light B, Loeb M, McElhaney J, Mackinnon-Cameron D, McCarthy A, Poirier M, Powis J, Richardson D, Semret M, Smith S, Smyth D, Stiver G, Trottier S, Valiquette L, Webster D, Ye L, McGeer A; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Serious Outcomes Surveillance Network; Toronto Invasive Bacterial Diseases Network (TIBDN).

Euro Surveill. 2014 Mar 6;19(9). pii: 20729.

18.

Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy.

Taylor S, Margolick J, Abughosh Z, Goldenberg SL, Lange D, Bowie WR, Bell R, Roscoe D, Machan L, Black P.

BJU Int. 2013 May;111(6):946-53. doi: 10.1111/j.1464-410X.2012.11637.x. Epub 2013 Mar 6.

19.

Phenotypic antibiotic resistance of Escherichia coli and E. coli O157 isolated from water, sediment and biofilms in an agricultural watershed in British Columbia.

Maal-Bared R, Bartlett KH, Bowie WR, Hall ER.

Sci Total Environ. 2013 Jan 15;443:315-23. doi: 10.1016/j.scitotenv.2012.10.106. Epub 2012 Nov 30.

PMID:
23202379
20.

A prospective randomized trial of povidone-iodine prophylactic cleansing of the rectum before transrectal ultrasound guided prostate biopsy.

Abughosh Z, Margolick J, Goldenberg SL, Taylor SA, Afshar K, Bell R, Lange D, Bowie WR, Roscoe D, Machan L, Black PC.

J Urol. 2013 Apr;189(4):1326-31. doi: 10.1016/j.juro.2012.09.121. Epub 2012 Oct 2.

PMID:
23041343
21.

Population-based study of the increased incidence of skin and soft tissue infections and associated antimicrobial use.

Marra F, Patrick DM, Chong M, McKay R, Hoang L, Bowie WR.

Antimicrob Agents Chemother. 2012 Dec;56(12):6243-9. doi: 10.1128/AAC.00649-12. Epub 2012 Sep 24.

22.

Ecosystem approach to promoting appropriate antibiotic use for children in indigenous communities in Ecuador.

Muñoz G, Mota L, Bowie WR, Quizhpe A, Orrego E, Spiegel JM, Yassi A.

Rev Panam Salud Publica. 2011 Dec;30(6):566-73.

PMID:
22358404
23.

Campylobacter spp. distribution in biofilms on different surfaces in an agricultural watershed (Elk Creek, British Columbia): using biofilms to monitor for Campylobacter.

Maal-Bared R, Bartlett KH, Bowie WR, Hall ER.

Int J Hyg Environ Health. 2012 Apr;215(3):270-8. doi: 10.1016/j.ijheh.2011.12.004. Epub 2011 Dec 26.

PMID:
22204983
24.

Establishing a community of practice of researchers, practitioners, policy-makers and communities to sustainably manage environmental health risks in Ecuador.

Spiegel JM, Breilh J, Beltran E, Parra J, Solis F, Yassi A, Rojas A, Orrego E, Henry B, Bowie WR, Pearce L, Gaibor J, Velasquez P, Concepcion M, Parkes M.

BMC Int Health Hum Rights. 2011 Nov 8;11 Suppl 2:S5. doi: 10.1186/1472-698X-11-S2-S5.

25.

Is the delay in diagnosis of pulmonary tuberculosis related to exposure to fluoroquinolones or any antibiotic?

Wang M, Fitzgerald JM, Richardson K, Marra CA, Cook VJ, Hajek J, Elwood RK, Bowie WR, Marra F.

Int J Tuberc Lung Dis. 2011 Aug;15(8):1062-8. doi: 10.5588/ijtld.10.0734.

PMID:
21740669
26.

Dexamethasone in Cryptococcus gattii central nervous system infection.

Phillips P, Chapman K, Sharp M, Harrison P, Vortel J, Steiner T, Bowie W.

Clin Infect Dis. 2009 Aug 15;49(4):591-5. doi: 10.1086/603554.

PMID:
19589083
27.

Antibiotic use in children is associated with increased risk of asthma.

Marra F, Marra CA, Richardson K, Lynd LD, Kozyrskyj A, Patrick DM, Bowie WR, Fitzgerald JM.

Pediatrics. 2009 Mar;123(3):1003-10. doi: 10.1542/peds.2008-1146.

PMID:
19255032
28.

Pulmonary actinomycosis complicating infliximab therapy for Crohn disease.

Cohen R, Bowie W, Enns R, Flint J, Fitzgerald M.

BMJ Case Rep. 2009;2009. pii: bcr11.2008.1262. doi: 10.1136/bcr.11.2008.1262. Epub 2009 May 10.

29.

Case report: failure of subcutaneous ivermectin in treating Strongyloides hyperinfection.

Leung V, Al-Rawahi GN, Grant J, Fleckenstein L, Bowie W.

Am J Trop Med Hyg. 2008 Dec;79(6):853-5.

PMID:
19052292
30.

Dealing with waterborne disease in Canada: challenges in the delivery of safe drinking water.

Maal-Bared R, Bartlett KH, Bowie WR.

Rev Environ Health. 2008 Apr-Jun;23(2):119-33. Review.

PMID:
18763540
31.

Community-associated CMRSA-10 (USA-300) is the predominant strain among methicillin-resistant Staphylococcus aureus strains causing skin and soft tissue infections in patients presenting to the emergency department of a Canadian tertiary care hospital.

Al-Rawahi GN, Reynolds S, Porter SD, Forrester L, Kishi L, Chong T, Bowie WR, Doyle PW.

J Emerg Med. 2010 Jan;38(1):6-11. doi: 10.1016/j.jemermed.2007.09.030. Epub 2008 Mar 6.

PMID:
18325716
32.

Perspectives on emerging zoonotic disease research and capacity building in Canada.

Stephen C, Artsob H, Bowie WR, Drebot M, Fraser E, Leighton T, Morshed M, Ong C, Patrick D.

Can J Infect Dis Med Microbiol. 2004 Nov;15(6):339-44.

33.
34.

Guidelines for the management of lyme disease : the controversy and the quandary.

Bowie WR.

Drugs. 2007;67(18):2661-6. No abstract available.

PMID:
18062716
35.

Pulmonary actinomycosis complicating infliximab therapy for Crohn's disease.

Cohen RD, Bowie WR, Enns R, Flint J, Fitzgerald JM.

Thorax. 2007 Nov;62(11):1013-4.

36.

A comparison of antibiotic use in children between Canada and Denmark.

Marra F, Monnet DL, Patrick DM, Chong M, Brandt CT, Winters M, Kaltoft MS, Tyrrell GJ, Lovgren M, Bowie WR.

Ann Pharmacother. 2007 Apr;41(4):659-66. Epub 2007 Mar 20.

PMID:
17374628
37.

Antibiotic use among children in British Columbia, Canada.

Marra F, Patrick DM, Chong M, Bowie WR.

J Antimicrob Chemother. 2006 Oct;58(4):830-9. Epub 2006 Aug 18.

PMID:
16921182
38.

Coordinated response to SARS, Vancouver, Canada.

Skowronski DM, Petric M, Daly P, Parker RA, Bryce E, Doyle PW, Noble MA, Roscoe DL, Tomblin J, Yang TC, Krajden M, Patrick DM, Pourbohloul B, Goh SH, Bowie WR, Booth TF, Tweed SA, Perry TL, McGeer A, Brunham RC.

Emerg Infect Dis. 2006 Jan;12(1):155-8.

39.

Parvovirus B19 in an immunocompetent adult patient with acute liver failure: an underdiagnosed cause of acute non-A-E viral hepatitis.

Ho JK, Tha SP, Coupland R, Dalal BI, Bowie WR, Sreenivasan GM, Krajden M, Yoshida EM.

Can J Gastroenterol. 2005 Mar;19(3):161-2.

PMID:
15776137
40.

Perspectives on emerging zoonotic disease research and capacity building in Canada.

Stephen C, Artsob H, Bowie WR, Drebot M, Fraser E, Leighton T, Morshed M, Ong C, Patrick D.

Can Vet J. 2005 Jan;46(1):65-71.

41.

Effect of formulary policy decisions on antimicrobial drug utilization in British Columbia.

Marra F, Patrick DM, White R, Ng H, Bowie WR, Hutchinson JM.

J Antimicrob Chemother. 2005 Jan;55(1):95-101. Epub 2004 Dec 8.

PMID:
15590717
42.

Per capita antibiotic consumption: how does a North American jurisdiction compare with Europe?

Patrick DM, Marra F, Hutchinson J, Monnet DL, Ng H, Bowie WR.

Clin Infect Dis. 2004 Jul 1;39(1):11-7. Epub 2004 Jun 1.

PMID:
15206046
43.

Availability and estimates of veterinary antimicrobial use in British Columbia.

Fraser E, Stephen C, Bowie WR, Wetzstein M.

Can Vet J. 2004 Apr;45(4):309-11.

44.

Novel cryptosporidium genotypes in sporadic cryptosporidiosis cases: first report of human infections with a cervine genotype.

Ong CS, Eisler DL, Alikhani A, Fung VW, Tomblin J, Bowie WR, Isaac-Renton JL.

Emerg Infect Dis. 2002 Mar;8(3):263-8.

45.

Clinical and microbiological follow-up of an outbreak of Yersinia pseudotuberculosis serotype Ib.

Press N, Fyfe M, Bowie W, Kelly M.

Scand J Infect Dis. 2001;33(7):523-6.

PMID:
11515763
46.

Computer-generated dot maps as an epidemiologic tool: investigating an outbreak of toxoplasmosis.

Eng SB, Werker DH, King AS, Marion SA, Bell A, Issac-Renton JL, Irwin GS, Bowie WR.

Emerg Infect Dis. 1999 Nov-Dec;5(6):815-9.

47.

Molecular epidemiology of cryptosporidiosis outbreaks and transmission in British Columbia, Canada.

Ong CS, Eisler DL, Goh SH, Tomblin J, Awad-El-Kariem FM, Beard CB, Xiao L, Sulaiman I, Lal A, Fyfe M, King A, Bowie WR, Isaac-Renton JL.

Am J Trop Med Hyg. 1999 Jul;61(1):63-9.

PMID:
10432058
48.

Epidemic and endemic seroprevalence of antibodies to Cryptosporidium and Giardia in residents of three communities with different drinking water supplies.

Isaac-Renton J, Blatherwick J, Bowie WR, Fyfe M, Khan M, Li A, King A, McLean M, Medd L, Moorehead W, Ong CS, Robertson W.

Am J Trop Med Hyg. 1999 Apr;60(4):578-83.

PMID:
10348231
49.

Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak.

Burnett AJ, Shortt SG, Isaac-Renton J, King A, Werker D, Bowie WR.

Ophthalmology. 1998 Jun;105(6):1032-7.

PMID:
9627653
50.

Detection of Toxoplasma gondii oocysts in drinking water.

Isaac-Renton J, Bowie WR, King A, Irwin GS, Ong CS, Fung CP, Shokeir MO, Dubey JP.

Appl Environ Microbiol. 1998 Jun;64(6):2278-80.

Supplemental Content

Support Center